Peter Meintjes

Chief Executive Officer at PACIFIC EDGE LIMITED

Net worth: 19 625 $ as of 2024-03-30

Health Technology

Consumer Services

Profile

Peter Meintjes is currently the Chief Executive Officer at Pacific Edge Ltd.
Prior to this, he was the Chief Executive Officer at Omixon Biocomputing Kft.
He received his doctorate degree from Auckland University in 2008 and also completed his undergraduate and graduate degrees at Auckland University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PACIFIC EDGE LIMITED 0.05%	2023-10-24	386,016 ( 0.05% )	19 625 $	2024-03-30

Peter Meintjes active positions

Companies	Position	Start
PACIFIC EDGE LIMITED	Chief Executive Officer	2022-01-16

All active positions of Peter Meintjes

Former positions of Peter Meintjes

Companies	Position	End
Omixon Biocomputing Kft Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Omixon Biocomputing Kft. provides diagnostics services. The firm specializes in data analysis, next-generation sequencing, software development, amplicon sequencing, NGS, HLA typing, HLA Assay and Software, Whole Gene Sequencing, Whole Exome Sequencing, HLA Genotyping kit, Omixon Academy, automation, epitope matching, and molecular diagnostics. The company was founded by Attila Berces and Márton Szoke in 2011 and is headquartered in Budapest, Hungary.	Chief Executive Officer	2020-04-19

See the detail of Peter Meintjes's experience

Training of Peter Meintjes

Auckland University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Meintjes's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
PACIFIC EDGE LIMITED	Health Technology

Private companies	1
Omixon Biocomputing Kft Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Omixon Biocomputing Kft. provides diagnostics services. The firm specializes in data analysis, next-generation sequencing, software development, amplicon sequencing, NGS, HLA typing, HLA Assay and Software, Whole Gene Sequencing, Whole Exome Sequencing, HLA Genotyping kit, Omixon Academy, automation, epitope matching, and molecular diagnostics. The company was founded by Attila Berces and Márton Szoke in 2011 and is headquartered in Budapest, Hungary.	Health Technology